Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11679110 Methods of treating disorders using CSF1R inhibitors

Patent 11679110 was granted and assigned to Deciphera Pharmaceuticals on June, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 2 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 2 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12102620 Combination therapy for the treatment of mastocytosis
0
Edits on 14 Aug, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 14 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12059411 Methods of treating gastrointestinal stromal tumors
0
"update inverses"
Golden AI profile picture
Golden AI
edited on 14 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12059410 Methods of treating gastrointestinal stromal tumors
0
Edits on 3 Jul, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 3 Jul, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12023327 Methods of treating gastrointestinal stromal tumors
0
"update inverses"
Golden AI profile picture
Golden AI
edited on 3 Jul, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12023326 Methods of treating gastrointestinal stromal tumors
0
"update inverses"
Golden AI profile picture
Golden AI
edited on 3 Jul, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12023325 Methods of treating gastrointestinal stromal tumors
0
Edits on 2 Mar, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 2 Mar, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11912668 GCN2 and perk kinase inhibitors and methods of use thereof
0
Edits on 21 Jun, 2023
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 21 Jun, 2023
Edits made to:
Infobox (+31 properties)
Article (+323 characters)
‌

 US Patent 11679110 Methods of treating disorders using CSF1R inhibitors

Article

Described herein are methods of treating cancers and other tumors related to the decreased proliferation, the depletion, or the repolarization of tumor-associated macrophages (TAMs) and treatment of associated disorders, including tenosynovial giant cell tumor (TGCT) and diffuse-type tenosynovial giant cell tumor (DTGCT).

Infobox
Is a
Patent
Patent
0
Patent Applicant
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals
0
Current Assignee
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
116791100
Date of Patent
June 20, 2023
0
Patent Application Number
173581370
Date Filed
June 25, 2021
0
Patent Citations
‌
US Patent 7342037 Anti-inflammatory medicaments
0
‌
US Patent 7531566 Anti-inflammatory medicaments
0
‌
US Patent 7666895 Anti-inflammatory medicaments
0
‌
US Patent 7737283 Anti-inflammatory medicaments
0
‌
US Patent 8163756 Enzyme modulators and treatments
0
‌
US Patent 8461179 Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
0
‌
US Patent 8486951 Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities
0
‌
US Patent 8586565 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
0
‌
US Patent 8637672 Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activities
0
‌
US Patent 8741911 Raf inhibitor compounds
0
‌
US Patent 8921565 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
0
‌
US Patent 8940756 Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
0
‌
US Patent 9012635 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
0
‌
US Patent 9187474 Raf inhibitor compounds
0
‌
US Patent 9309224 N-acyl-N′-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities
0
‌
US Patent 9334267 RAF inhibitor compounds
0
‌
US Patent 9382228 N-acyl-N′-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities
0
‌
US Patent 9387202 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
0
‌
US Patent 9457019 Methods for inhibiting tie-2 kinase useful in the treatment of cancer
0
Patent Primary Examiner
‌
Raymond J. Henley, III
0
CPC Code
‌
A61P 35/00
0
‌
A61P 35/02
0
‌
A61K 31/505
0

Find more entities like US Patent 11679110 Methods of treating disorders using CSF1R inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.